In lung adenocarcinoma, TBX21 expression enhances tumor cell recognition and clearance by the immune system (50, 51), while increased TBX21 expression in cutaneous melanoma is associated with a better prognosis (49). The gene discussed is TBX21; the disease is lung adenocarcinoma.